 |
| Professor Jamie Layland |
Research investigating the impact of common gout medication Colchicine, in patients with acute coronary syndrome, led by Peninsula Health and Monash University cardiologist Professor Jamie Layland, has been published in premier cardiology journal Circulation.
The COPS Trial (COlchicine in Patients with Acute Coronary Syndromes) is a multicentre, double-blind, randomised, placebo-controlled trial to assess the impact of low-dose colchicine on long-term cardiovascular outcomes in patients presenting with acute coronary syndromes. This is the first Australian multi-centered clinical trial to be led by Peninsula Health.
